PROGNOSTIC SIGNIFICANCE OF GLYCATED HEMOGLOBIN LEVEL IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Document Type : Preliminary preprint short reports of original research

Authors

1 Department of Cardiology and Angiology ,Faculty of Medicine, Alexandria ,University

2 Departement of Cardiology and Angiology of Medecine,University of Alexandria.

3 Department of Cardiology and Angiology, Faculty of Medicine, University of Alexandria

4 Department of Clinical and Chemical Pathology, Faculty of Medicine University of Alexandria.

5 Cardiology and Angiology Department, Alexandria university hospital, Alexandria University, Alexandria, Egypt

Abstract

Introduction: Diabetes is a common comorbidity among patients hospitalized with ACS, with a rising prevalence over the previous 10 years and a high mortality rate. Approximately 25% of patients with STEMI have a history of diabetes, whereas over 40% have undiagnosed T2DM or pre-diabetes. patients who have ASCVD, AF, or HF should be tested for diabetes, especially if they were admitted with an acute event. People who have stress hyperglycemia—defined as elevated blood sugar levels during hospitalization with a normal HbA1c—should also get post-discharge glucose assessment, to exclude prolonged abnormal glucose metabolism. Regardless of diabetes status, STEMI patients presented with hyperglycemia on admission have higher mortality rate than STEMI patients without hyperglycemia, there is a stronger correlation between blood glucose levels and mortality than between the prevalence of diabetes, Therefore, it is highly advised that all subjects have their blood glucose levels checked as soon as possible.

Aim: The aim of this study is to assess the prognostic value of admission HbA1C level in patients undergoing primary PCI in Alexandria University Hospitals, on outcome of primary PCI and major adverse cardiovascular and cerebrovascular events.

Keywords

ALEXMED ePosters
Volume 7, Issue 1
January 2025
Pages 38-39

Files

Share

How to cite

Statistics